Sulindac
- Product NDC
- 70934-550
- 11-digit product format
- 709340550
- Labeler code
- 70934
- Product ID
- 70934-550_ac8afd99-4e7c-4e77-e053-2a95a90a2da3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sulindac
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA071795
- Marketing category
- ANDA
- Marketing start
- 2020-02-06
- Marketing end
- 0000-00-00
- Substance
- SULINDAC
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-550-30 | 70934055030 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-550-30) | 30 tablet | 2020-02-06 | 0000-00-00 | No | No | Current |